567
Views
9
CrossRef citations to date
0
Altmetric
General

Gender differences in presentation of behavioral and psychological symptoms in Alzheimer’s disease in Taiwan

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 1342-1347 | Received 04 Dec 2018, Accepted 20 Feb 2019, Published online: 26 Mar 2019

Reference

  • Ames, R. T., & Hall, D. L. (1998). Thinking from the Han: Self, Truth, and Transcendence in Chinese and Western Culture. Albany, NY: State University of New York Press.
  • Berlow, Y. A., Wells, W. M., Ellison, J. M., Sung, Y. H., Renshaw, P. F., & Harper, D. G. (2009). Neuropsychiatric correlates of white matter hyperintensities in Alzheimer's disease. International Journal of Geriatric Psychiatry, 25(8), 780–788.
  • Cerejeira, J., Lagarto, L., & Mukaetova-Ladinska, E. B. (2012). Behavioral and psychological symptoms of dementia. Frontiers in Neurology, 3, 73.
  • Chen, S. F., Liu, M. H., Chen, N. C., Horng, H. D., Tsao, W. L., Chang, C. C., & Chang, Y. T. (2018). Educational effects on ascertain dementia 8-item informant questionnaire to detect dementia in the Taiwanese population. International Psychogeriatrics, 30(8), 1189–1197.
  • Chou, P. S., Wu, M. N., Chou, M. C., Chien, I., & Yang, Y. H. (2017). Angiotensin-converting enzyme insertion/deletion polymorphism and the longitudinal progression of Alzheimer's disease. Geriatrics & Gerontology International, 17, 1544–1550.
  • Chui, H. C., Lyness, S. A., Sobel, E., & Schneider, L. S. (1994). Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer's disease. Archives of Neurology, 51(7), 676–681.
  • Chung, E. J., Babulal, G. M., Monsell, S. E., Cairns, N. J., Roe, C. M., & Morris, J. C. (2015). Clinical features of Alzheimer disease with and without Lewy bodies. JAMA Neurology, 72(7), 789–796.
  • Colombo, D., Caltagirone, C., Padovani, A., Sorbi, S., Spalletta, G., Simoni, L., … Zagni, E. &. (2018). Gender differences in neuropsychiatric symptoms in mild to moderate Alzheimer's disease patients undergoing switch of cholinesterase inhibitors: A post hoc analysis of the EVOLUTION Study. Journal of Women's Health (Larchmt), 27(11), 1368–1377.
  • Corder, E. H., Ghebremedhin, E., Taylor, M. G., Thal, D. R., Ohm, T. G., & Braak, H. (2004). The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism. Annals of the New York Academy of Sciences, 1019(1), 24–28.
  • Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994). The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology, 44(12), 2308–2314.
  • Damoiseaux, J. S., Seeley, W. W., Zhou, J., Shirer, W. R., Coppola, G., Karydas, A., … Greicius, M. D. (2012). Gender modulates the APOE ε4 effect in healthy older adults: convergent evidence from functional brain connectivity and spinal fluid tau levels. Journal of Neuroscience, 32(24), 8254–8262.
  • Farrer, L. A., Cupples, L. A., Haines, J. L., Hyman, B., Kukull, W. A., & Mayeux, R. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA: The Journal of the American Medical Association, 278(16), 1349–1356.
  • Finkel, S. I., Costa, e., Silva, J., Cohen, G., Miller, S., & Sartorius, N. (1997). Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. International Psychogeriatrics, 8(S3), 497–500.
  • Fischer, C. E., Ismail, Z., & Schweizer, T. A. (2012). Delusions increase functional impairment in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 33(6), 393–399.
  • Fleisher, A., Grundman, M., Jack, C. R., Petersen, R. C., Taylor, C., Kim, H. T., … Thal, L. J. (2005). Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. Archives of Neurology, 62(6), 953–957.
  • Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189–198.
  • Heise, V., Filippini, N., Trachtenberg, A. J., Suri, S., Ebmeier, K. P., & Mackay, C. E. (2014). Apolipoprotein E genotype, gender and age modulate connectivity of the hippocampus in healthy adults. Neuroimage, 98, 23–30.
  • Hopkins, M. W., & Libon, D. J. (2005). Neuropsychological functioning of dementia patients with psychosis. Archives of Clinical Neuropsychology, 20(6), 771–783.
  • Huang, M. H., & Kuo, C. L. (2009). Correlation study of career barriers and coping strategies among female nurses. Journal of Nursing and Healthcare Research, 5, 91–99.
  • Janicki, S. C., & Schupf, N. (2010). Hormonal influences on cognition and risk for Alzheimer's disease. Current Neurology and Neuroscience Reports, 10(5), 359–366.
  • Katona, C., Livingston, G., Cooper, C., Ames, D., Brodaty, H., & Chiu, E. (2007). International Psychogeriatric Association consensus statement on defining and measuring treatment benefits in dementia. International Psychogeriatrics, 19(3), 345–354.
  • Kendell, R. E. (1987). Diagnosis and classification of functional psychoses. British Medical Bulletin, 43(3), 499–513.
  • Kim, J., Fischer, C. E., Schweizer, T. A., & Munoz, D. G. (2017). Gender and Pathology-Specific Effect of Apolipoprotein E Genotype on Psychosis in Alzheimer's Disease. Current Alzheimer Research, 14, 834–840.
  • Kua, E. H., Ho, E., Tan, H. H., Tsoi, C., Thng, C., & Mahendran, R. (2014). The natural history of dementia. Psychogeriatrics: The Official Journal of the Japanese Psychogeriatric Society, 14(3), 196–201.
  • Lindpaintner, K., Pfeffer, M. A., Kreutz, R., Stampfer, M. J., Grodstein, F., LaMotte, F., … Hennekens, C. H. (1995). A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. New England Journal of Medicine, 332(11), 706–711.
  • McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34(7), 939–944.
  • Michels, A., Multhammer, M., Zintl, M., Mendoza, M. C., & Klünemann, H. H. (2012). Association of apolipoprotein E ε4 (ApoE ε4) homozygosity with psychiatric behavioral symptoms. Journal of Alzheimer's Disease, 28(1), 25–32.
  • Morris, J. C. (1993). The clinical dementia rating (CDR): current version and scoring rules. Neurology, 43(11), 2412–2414.
  • Murray, P. S., Kirkwood, C. M., Gray, M. C., Fish, K. N., Ikonomovic, M. D., Hamilton, R. L., … Sweet, R. A. (2014). Hyperphosphorylated tau is elevated in Alzheimer's disease with psychosis. Journal of Alzheimer's Disease, 39(4), 759–773.
  • Ochoa, S., Usall, J., Cobo, J., Labad, X., & Kulkarni, J. (2012). Gender differences in schizophrenia and first-episode psychosis: A comprehensive literature review. Schizophrenia Research and Treatment, 916198, 2012, 1.
  • Ott, B. R., Tate, C. A., Gordon, N. M., & Heindel, W. C. (1996). Gender differences in the behavioral manifestations of Alzheimer's disease. Journal of the American Geriatrics Society, 44(5), 583–587.
  • Panza, F., Frisardi, V., Seripa, D., D’Onofrio, G., Santamato, A., Masullo, C., … Pilotto, A. (2012). Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease. Ageing Research Reviews, 11(1), 87–103.
  • Pink, A., Stokin, G. B., Bartley, M. M., Roberts, R. O., Sochor, O., Machulda, M. M., … Geda, Y. E. (2015). Neuropsychiatric symptoms, APOE ε4, and the risk of incident dementia: a population-based study. Neurology, 84(9), 935–943.
  • Pinares-Garcia, P., Stratikopoulos, M., Zagato, A., Loke, H., & Lee, J. (2018). Sex: A Significant Risk Factor for Neurodevelopmental and Neurodegenerative Disorders. Brain Seiences, 8, pii–E154.
  • Ramakers, I. H., Verhey, F. R., Scheltens, P., Hampel, H., Soininen, H., Aalten, P., … Visser, P. J. (2013). Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment. Psychological Medicine, 43(05), 911–920.
  • Rigat, B., Hubert, C., Corvol, P., & Soubrier, F. (1992). PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Research, 20(6), 1433.
  • Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P., & Soubrier, F. (1990). An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. Journal of Clinical Investigation, 86(4), 1343–1346.
  • Ropacki, S. A., & Jeste, D. V. (2005). Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003. The American Journal of Psychiatry, 162(11), 2022–2030.
  • Tao, Y., Peters, M. E., Drye, L. T., Devanand, D. P., Mintzer, J. E., Pollock, B. G., … Munro, C. A. (2018). Sex differences in the neuropsychiatric symptoms of patients with Alzheimer's Disease. American Journal of Alzheimer's Disease and Other Dementias, 33(7), 450–457.
  • Trzepacz, P. T., Yu, P., Bhamidipati, P. K., Willis, B., Forrester, T., Tabas, L., … Saykin, A. J. (2013). Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer's disease. Alzheimers & Dementia, 9, S95–S104.
  • Ungar, L., Altmann, A., & Greicius, M. D. (2014). Apolipoprotein E, gender, and Alzheimer's disease: an overlooked, but potent and promising interaction. Brain Imaging and Behavior, 8(2), 262–273.
  • Van der Flier, W. M., Staekenborg, S., Pijnenburg, Y. A., Gillissen, F., … Scheltens, P. (2007). Apolipoprotein E genotype influences presence and severity of delusions and aggressive behavior in Alzheimer disease. Dementia and Geriatric Cognitive Disorders, 23, 42–46.
  • Xing, Y., Qin, W., Li, F., Jia, X. F., & Jia, J. (2012). Apolipoprotein E ε4 status modifies the effects of sex hormones on neuropsychiatric symptoms of Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 33(1), 35–42.
  • Xing, Y., Tang, Y., & Jia, J. (2015). Sex differences in neuropsychiatric symptoms of Alzheimer's Disease: The modifying effect of Apolipoprotein E ε4 Status. Behavioural Neurology, 2015, 1.
  • Zandi, P. P., Carlson, M. C., Plassman, B. L., Welsh-Bohmer, K. A., Mayer, L. S., Steffens, D. C., … Investigators, C. C. M. S. (2002). Hormone replacement therapy and incidence of alzheimer disease in older women: The cache county study. JAMA, 288(17), 2123–2129.
  • Zuidema, S. U., de, Jonghe, J. F., Verhey, F. R., & Koopmans, R. T. (2009). Predictors of neuropsychiatric symptoms in nursing home patients: influence of gender and dementia severity. International Journal of Geriatric Psychiatry, 24(10), 1079–1086.
  • Zuo, L., van, Dyck, C. H., Luo, X., Kranzler, H. R., Yang, B. Z., & Gelernter, J. (2006). Variation at APOE and STH loci and Alzheimer's disease. Behavioral and Brain Functions, 2, 13

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.